Literature DB >> 22890459

Management of children with ambulatory cerebral palsy: an evidence-based review. Commentary by Hugh Williamson Gait Laboratory staff.

Pam Thomason1, Jill Rodda, Morgan Sangeux, Paulo Selber.   

Abstract

The evaluation of complex interventions, such as Single Event Multilevel Surgery (SEMLS) requires more than randomized controlled trials. Rehabilitation following SEMLS is prolonged and the outcomes of interest may not be apparent for 5 years or more after the surgery. We suggest long term, prospective cohort studies with objective outcome measures be recognized as of equal importance to randomized controlled trials. The evidence in support of instrumented gait analysis (IGA) is also reviewed. We suggest that clinical levels of evidence are not an appropriate method to evaluate a measurement tool. Specifically, IGA should be evaluated in terms of validity, reliability and cost effectiveness. We demonstrate that the use of IGA has improved medium and long term outcomes in ambulant children with cerebral palsy in a center where IGA has been used routinely both for planning SEMLS and for monitoring outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22890459     DOI: 10.1097/BPO.0b013e31825b6136

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  2 in total

1.  Kinetic and Kinematic Analysis of Gait in Type IV Osteogenesis Imperfecta Patients: A Comparative Study.

Authors:  Subham Badhyal; Sandip R Dhole; Nirmal Raj Gopinathan; Mandeep Singh Dhillon; Vandana Dhiman; Anshu Dhar Jayal; Jitendra Prasad
Journal:  Indian J Orthop       Date:  2019 Jul-Aug       Impact factor: 1.251

2.  Patients' and parents' views about lower limb orthopaedic surgery for ambulant children and young people with cerebral palsy: a qualitative evidence synthesis.

Authors:  Hajar Almoajil; Tim Theologis; Helen Dawes; Jackie Parsonage; Jo Pierce; Sally Hopewell; Francine Toye
Journal:  J Child Orthop       Date:  2020-12-01       Impact factor: 1.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.